The loan repayment program — created in collaboration with Clasp, a national leader in retention-driven healthcare recruiting — positions AHN as an employer of choice for early-career CRNA talent

PITTSBURGH, Sept. 21, 2026 /PRNewswire/ -- Allegheny Health Network (AHN) today announced the launch of a new national recruitment and loan repayment program designed to strengthen the pipeline of Certified Registered Nurse Anesthetists (CRNAs) in Western Pennsylvania.

The workforce investment campaign aims to address the ongoing regional and national shortages in CRNAs by reducing financial barriers to education and attracting early-career CRNA talent. A CRNA is an advanced practice registered nurse who specializes in administering anesthesia and monitoring patients before, during, and after surgical procedures.

Without an adequate supply of CRNAs, health systems have trouble meeting patient access demands for surgical procedures, especially elective procedures. Operating rooms face delayed starts and extended turnaround times, and CRNAs themselves experience higher burnout rates.

Through a new collaboration with Clasp, a national leader in retention-driven healthcare recruiting, AHN will provide employer-sponsored student loan repayment for qualified nurse anesthesia students who commit to joining the organization full-time as a CRNA after graduation.

The collaboration with Clasp allows AHN to reach a much broader, national population of CRNA candidates.

Clasp, based in Boston, connects employers to healthcare students through its national retention-driven recruitment platform. By enabling health care systems to sponsor loan repayment tied to early job commitments, Clasp helps employers to secure job commitments while students are still in school, and gives students and early-career professionals access to guaranteed debt relief, deferring loan repayment until after they hit retention milestones.

AHN is Clasp's first Pennsylvania collaborator.

How it works for students:

- Employer Matching: Students apply through Clasp and match with participating hospitals or health networks (such as AHN) that need nurse anesthetists.

- Work Commitment: Students agree to a multi-year employment term with AHN, in exchange for a debt repayment commitment.

- Direct Payments: Once the student begins full-time employment, AHN makes regular monthly payments directly to the federal or private student loan servicer, through the Clasp platform.

- No Claw-backs: Employees keep every dollar contributed by the employer toward principal balance.

Loan repayment is distributed over the employee's first three years of employment through the Clasp platform.¹

The launch comes as healthcare organizations nationwide continue to face significant shortages of CRNAs and other advanced practice clinicians, with hospitals competing aggressively for a limited pool of hard-to-hire talent. By investing in future CRNAs before they enter the workforce, AHN is taking a proactive approach to building a strong talent pipeline while helping nurse anesthesia students transition from school into high-impact clinical careers.

"Healthcare systems across the country are exploring innovative ways to recruit and retain talented clinical professionals, and anesthesia is clearly a priority for most organizations," said Stacy Kittridge, VP, Human Resources Highmark and AHN. "Working with Clasp gives us the opportunity to engage CRNA students earlier in their training, help ease one of the biggest financial barriers of pursuing this career path, and build lasting relationships with clinicians who will be critical to AHN's future workforce."

Eligible CRNA students who are within two years of graduation may apply to the program, receive an employment commitment prior to graduation, and begin receiving student loan repayment once they join AHN full-time.

"Healthcare organizations are rethinking how they attract and retain hard-to-hire clinical talent in an increasingly competitive labor market," said Tess Michaels, CEO & Founder of Clasp. "Allegheny Health Network is leading the way by investing in nurse anesthesia students before they graduate, creating a pathway that helps reduce student debt while building a stronger, more resilient CRNA workforce for Western Pennsylvania."

The initiative supports AHN's broader workforce strategy focused on talent attraction, retention, pipeline development, and expanding access to meaningful healthcare careers throughout the region.

Nurse anesthesia students interested in launching their careers with Allegheny Health Network are encouraged to visit careers.ahn.org or learn more about the program at clasp.com/alleghenyhealthnetwork.

About Allegheny Health Network

Allegheny Health Network (AHN.org) is an integrated health care delivery system serving the greater Western Pennsylvania region. The network is composed of 16 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home- and community-based health services, a research institute, and a group purchasing organization. AHN provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, cardiovascular disease, cancer care, orthopedic surgery, neurology and neurosurgery, women's health, diabetes and more. AHN employs approximately 27,000 people, has 3,000 physicians on its medical staff, and serves as a clinical campus for Drexel University College of Medicine, Lake Erie College of Osteopathic Medicine and Duquesne University Nasuti College of Osteopathic Medicine.

About Clasp

Clasp is a venture-backed fintech company helping employers build stronger talent pipelines through pre-recruitment and employer-sponsored student loan repayment. By aligning education financing with workforce demand, Clasp reduces risk for employers, schools, and students alike. Learn more at clasp.com.

¹ If qualified, selected, and employed full-time by Allegheny Health Network, AHN will pay up to $110,000 toward eligible, synced student loans via the Clasp platform in annual lump-sum installments: up to $20,000 after 12 months of employment, up to $30,000 after 24 months of employment, and up to $60,000 after 36 months of employment. Program is open to full-time team members only; program selection is not guaranteed and is determined by AHN, not Clasp. Individuals may be subject to income tax on some or all loan payments made on their behalf. See program terms at clasp.com/students.

SOURCE Allegheny Health Network

Share this article

DALLAS, Sept. 21, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP continues the strategic growth of its Finance Practice with the addition of Shan A. Khan as a shareholder in its Dallas office.

Khan, who joins from Kirkland & Ellis LLP, represents private equity sponsors, private credit funds, financial institutions, and public and private companies in complex financing transactions. His practice focuses on leveraged finance, acquisition financings, private credit transactions, and special situations matters, with experience spanning the energy, infrastructure, technology, manufacturing, health care, hospitality, and life sciences sectors.

"Greenberg Traurig's commitment to Texas runs deep, and our continued growth in the state reflects a deliberate focus on bringing in top-tier talent in areas of strategic importance to our clients," Executive Chairman Richard A. Rosenbaum said. "Shan's sophisticated finance practice and broad transactional experience make him an excellent addition to our Texas platform and our global capabilities."

Over the past decade, Khan has advised on transactions and financings with an aggregate value of more than $75 billion, ranging from middle-market financings to multibillion-dollar corporate transactions. His broad experience across the capital structure includes traditional lending, private credit, restructuring-related financings, and innovative solutions for companies navigating growth, acquisitions, and changing market conditions.

"Our clients are looking for counsel who can navigate increasingly complicated financing and transactional challenges," Global Finance Practice Co-Chair Arleen A. Nand said. "In addition to his impressive credentials and transactional experience, Shan is a highly collaborative lawyer whose practice complements many of our existing strengths. His versatile skill set will broaden the services we provide across the market, and we look forward to working closely with him as we continue to deepen our syndicated finance capabilities."

For Khan, it was Greenberg Traurig's entrepreneurial platform and continued investment in its finance capabilities that drew him to the firm.

"I am impressed by the firm's culture of collaboration, the strength of its finance platform, and the opportunities to work across practices and offices. I am excited to join the team and help clients navigate an increasingly dynamic financing market," Khan said.

Khan earned his J.D. from Columbia Law School, his A.M. in Near Eastern Languages and Civilizations from Harvard University, and his B.A. from The University of Texas at Austin. He is admitted to practice in Texas.

About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI "Best of the Best Recommended Law Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.

SOURCE Greenberg Traurig, LLP

Share this article

NEW YORK, Sept. 21, 2026 /PRNewswire/ -- Rutika Mehta, MD, MPH, a nationally recognized gastrointestinal (GI) medical oncologist, has joined NYU Langone Health's Perlmutter Cancer Center as director of upper GI medical oncology, further expanding the center's clinical and research programs for patients with upper GI cancers, including cancers of the esophagus and stomach.

Dr. Mehta is widely recognized for building multidisciplinary care programs and innovative clinical trials for upper GI cancers. Her research focuses on personalizing cancer treatment through molecular profiling, or detailed testing of a tumor's biology, and blood tests such as circulating tumor DNA tests, helping guide patients to the therapies most likely to benefit them.

Her arrival marks an important step in the continued growth of Perlmutter Cancer Center's Gastrointestinal Cancer Center, which brings together specialists in medical oncology, surgery, radiation oncology, gastroenterology, pathology, radiology, nutrition, and supportive care to deliver coordinated, personalized treatment. In her new role, Dr. Mehta will work closely with Noah A. Cohen, MD, section chief of complex GI surgical oncology, to further strengthen multidisciplinary care and expand clinical research opportunities.

"Dr. Mehta is an outstanding addition to Perlmutter Cancer Center at an important time in the growth of our GI Cancer Center," said Manuel Hidalgo Medina, MD, co-director of the GI Cancer Center. "Her expertise in upper GI cancers, commitment to multidisciplinary care, and extensive experience developing clinical trials will strengthen our ability to provide patients with access to innovative treatments while advancing research to improve outcomes."

Dr. Mehta treats patients with a wide range of GI cancers, specializing in cancers of the esophagus, stomach, and gastroesophageal junction—where the esophagus meets the stomach. Because these cancers often require a complex combination of treatments, she emphasizes a team-based approach that tailors care to each patient's needs and goals.

"Patients with esophageal and gastric cancers need a team that brings together the best science, the right expertise, and a clear understanding of what matters most to them," said Dr. Mehta. "I am excited to join NYU Langone and build on the growth of the GI Cancer Center by expanding personalized, biomarker-driven care and access to clinical trials, while ensuring that patients and their families feel informed and supported throughout their care."

At Perlmutter Cancer Center, Dr. Mehta will continue to expand the clinical trials available to patients with upper GI cancers, including investigator-initiated studies and trials evaluating new targeted and biomarker-driven therapies. She also serves on the National Cancer Institute's Upper GI Task Force, which helps shape national clinical research strategies for upper GI cancers.

About Dr. Mehta

Dr. Mehta joined NYU Langone from Weill Cornell Medicine, where she established an Upper GI Working Group to advance clinical and research collaboration. Previously, at Moffitt Cancer Center in Tampa, Florida, she helped build its Upper GI Malignancies Program and developed a robust clinical trials portfolio that gave patients access to new treatment options.

Her research has included clinical trials evaluating targeted therapies, immunotherapies, antibody-drug conjugates, and cellular therapies for GI cancers. She has particular expertise in HER2-positive gastroesophageal cancers and participated in the clinical development of zanidatamab, a HER2-targeted therapy. Her work also explores circulating tumor DNA and comprehensive molecular profiling to better understand treatment response, recurrence, and resistance.

In addition to her clinical and research leadership, Dr. Mehta is active in patient education and advocacy. She works closely with patient advocacy organizations, including Debbie's Dream Foundation and Hope for Stomach Cancer, participating in patient support groups, educational programs, and community events focused on GI cancers.

About NYU Langone Health

NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone No. 1 out of 118 comprehensive academic medical centers across the nation four years in a row, and it continues to have the most No. 1– and top 10–ranked specialties among medical centers in the United States, according to U.S. News & World Report. NYU Langone offers a comprehensive range of medical services with one high standard of care across seven inpatient locations, its Perlmutter Cancer Center, and more than 330 outpatient locations in the New York City area and Florida. The system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise.

Media Inquiries:

Lacy Scarmana

Phone: 332-215-3613

[email protected]

SOURCE NYU Langone Health

Share this article

SWCA Launches Regulatory Radar to Help Project Teams Anticipate Environmental Regulatory Change

PHOENIX, Sept. 21, 2026 /PRNewswire/ -- SWCA Environmental Consultants has launched SWCA's Regulatory Radar, a subscription-based regulatory intelligence platform that helps project teams anticipate and adapt to environmental regulatory changes before they affect budgets, reviews, permitting timelines and compliance obligations.

The regulatory environment for infrastructure, energy and development projects is moving quickly, leaving many teams to track dense policy changes while also managing active projects. Regulatory Radar helps organizations understand what changed, why it matters and what actions they should consider before a regulatory shift appears as a surprise in a comment letter, permit condition, inspection finding or project delay.

"Regulatory changes can create uncertainty for organizations responsible for complex projects," said Infrastructure Policy and Permitting Strategy Director Ross Pilotte at SWCA. "Regulatory Radar helps teams move from reaction to readiness by connecting policy developments with the practical context they need to make better project decisions."

Powered by SWCA's regulatory and technical leaders, Regulatory Radar combines policy insight with real-world experience across permitting, environmental review, compliance requirements and project delivery. Each insight includes the SWCA Lens, where SWCA advisors explain how a regulatory development may play out in practice, what they are seeing across projects and which issues may deserve closer attention.

Unlike industry newsletters that summarize what changed or legal alerts that explain what a rule requires, Regulatory Radar connects regulatory developments to the operational decisions clients face every day. It brings the value of sitting across the table from an SWCA advisor and asking, "What could this mean for my project?"

Regulatory Radar currently supports audiences focused on power and energy, infrastructure and construction compliance. Subscribers receive portal access and targeted alerts when regulatory developments may affect inspections, permits, schedules, budgets or compliance obligations. In a world of noise, Regulatory Radar provides the steady guidance project teams can use to navigate change with confidence.

Subscriptions are available for students, individuals and enterprise accounts, giving subscribers access to timely regulatory insights and project-centered guidance as new developments take shape.

About SWCA

Founded in 1981, SWCA is a 100% employee-owned environmental and management consulting firm. With a mission to be the best workplace and industry leader in sustainability, we combine scientific expertise and in-depth knowledge of the industries we serve to tackle global environmental challenges. Our experts deliver comprehensive solutions in environmental planning and permitting, cultural resources management, biological and ecological services, water resources management, resilience services, air quality, and engineering. Sound Science. Creative Solutions. www.swca.com.

Media Contact

Jara Sturdivant-Wilson

SWCA Environmental Consultants

Ph: (402) 257-1480

[email protected]

SOURCE SWCA Environmental Consultants

Share this article

Knight to Build on the Global Studio Foundation Established by Jean Venneman, Who Will Retire After More Than 30 Years in Gaming

LAS VEGAS, Sept. 21, 2026 /PRNewswire/ -- IGT announced today that, Jamie Knight will assume the role of Chief Studios Officer on Jan. 1, 2027, succeeding Jean Venneman, who will retire at the end of 2026 following more than 30 years in gaming. Knight will build on the strong foundation established under Venneman's leadership and lead IGT's continued studio investments, driving innovation across game design, content development and studio operations.

Knight brings two decades of experience across the industry's largest suppliers, with deep expertise in translating creative vision into player-favorite content. Having begun her career as a creative, she understands the collaborative process required to transform original concepts into successful products, a perspective that will inform her leadership of studio operations.

Jean Venneman, who will retire on December 31, 2026, began her career at IGT in the early 1990s and went on to hold senior leadership roles across product development, licensing, technology and operations before rejoining IGT in 2024. Since returning, she has rebuilt the company's global studio operations from the ground up. Under her leadership, she assembled and empowered a world-class studio team with more than 1,200 employees, established shared best practices across studio cultures and created the operational and creative foundation that positions IGT and Everi for accelerated growth.

"Jean's leadership created the foundation for this next phase of growth," said Hector Fernandez, IGT CEO. "She brought together talented teams, strengthened how our studios operate and raised the bar for creative and operational excellence. We are deeply grateful for everything she has contributed to our organization and our industry. Jamie's combination of creative instinct, studio leadership and focus on innovation in design and math will build on that momentum and unlock new possibilities across our combined studio organization."

As Chief Studios Officer, Knight will establish clear priorities for studio teams, drive innovation in game mechanics and mathematical modeling, and create an environment where creative talent can do exceptional work. Her vision centers on delivering the most dynamic and engaging content that meets the evolving demands of players and operators globally.

"I'm energized to lead our studio teams and build on the strong foundation in place," said Jamie Knight, incoming Chief Studios Officer. "Together with our talented teams across IGT and Everi, we'll push the boundaries of what's possible in game design, content strategy, and math innovation to deliver world-class experiences on the floor."

"Returning to this organization and helping strengthen our global studio organization has been a meaningful way to close my career," said Jean Venneman, Chief Studios Officer. "I am incredibly proud of our studio teams and the foundation we have created. I am confident Jamie will carry that momentum forward and help unlock the next phase of our growth."

For more information, follow IGT on Facebook and LinkedIn or watch IGT videos on YouTube.

About IGT

IGT is a leading global provider of gaming, digital and financial technology solutions, formed through the combination of International Game Technology PLC's Gaming & Digital Business and Everi Holdings Inc. IGT and Everi's offering spans gaming machines, game content and systems, iGaming, sports betting, cash access, loyalty and player engagement solutions, enabling it to deliver integrated, customer-centric experiences across land-based and digital environments. Organized into Gaming, Digital and FinTech business units, the organization drives innovation, efficiency and value for casino, digital and hospitality operators worldwide. The company is headquartered in Las Vegas.

Contact:

Phil O'Shaughnessy, Global Communications

Toll free in U.S./Canada +1 (844) IGT-7452

Outside U.S./Canada +1 (775) 448-0257

© 2026 IGT

The trademarks and/or service marks used herein are either trademarks or registered trademarks of IGT, its affiliates or its licensors.

SOURCE IGT

Share this article

OAK BROOK, Ill., Sept. 21, 2026 /PRNewswire/ -- The National Insurance Crime Bureau (NICB), the insurance industry's association dedicated to predicting, preventing, and prosecuting insurance crime and fraud, announces that David Glawe will step down as President and Chief Executive Officer in October after six years of service leading the nonprofit organization.

"On behalf of the Board of Governors, I want to thank David for his six years of service to NICB and his commitment to its important mission," said Nick Seminara, Chairman of the NICB Board of Governors. "We appreciate his contributions to the organization and wish him well as he prepares for his next chapter."

Glawe reflected on his time with NICB and the organization's mission:

"It has been a privilege to serve NICB and to work alongside such a talented and committed team. I have tremendous respect for the work they do every day and for the mission we share—bringing together the insurance industry, law enforcement, and our many partners to fight insurance fraud and crime and protect the public.

I am proud of what we have accomplished together over the past six years and grateful for the dedication, expertise, and commitment I have seen throughout the organization."

Glawe will work with the Board and NICB leadership team through his departure to support an orderly transition. The Board will announce its leadership transition plans at the appropriate time.

NICB remains focused on its mission and on continuing to strengthen its capabilities and partnerships in the fight against insurance crime and fraud.,

About the National Insurance Crime Bureau: Headquartered in Oak Brook, Ill., the National Insurance Crime Bureau (NICB) is the nation's leading not-for-profit organization exclusively dedicated to combatting and preventing insurance crime through Intelligence, Analytics, and Operations; Education and Crime Prevention; and Strategy, Policy, and Advocacy. NICB is supported by more than 1,200 property and casualty insurance companies and self-insured organizations. To learn more, visit NICB.org.

SOURCE National Insurance Crime Bureau (NICB)

Share this article

Ribbon-cutting event brings the community together to celebrate a milestone in the company's U.S. growth

NEWTOWN SQUARE, Pa., Sept. 21, 2026 /PRNewswire/ -- Boiron, the world leader in homeopathic medicines, celebrated the grand opening of its new 78,898-square-foot logistics center with a ribbon-cutting and community celebration on Sept. 16. More than 200 guests, including local elected officials, business partners and employees, attended the event to mark the significant milestone.

Guests enjoyed a festive atmosphere that featured elevated food and drinks, photo opportunities and guided tours of the new facility. A wildflower bouquet-building booth added a hands-on, community-focused touch, giving attendees a memorable way to take a piece of the celebration home with them.

Located approximately 1 mile from Boiron's U.S. headquarters, this state-of-the-art, temperature-controlled facility consolidates operations previously housed in two nearby warehouses. It features energy-efficient mechanical systems, 24-hour surveillance, large windows that provide natural light and four electric vehicle charging stations for employees to use. A team of 28 employees, including eight new hires, operates the center. The centralized operation increases storage capacity, streamlines inventory management and product distribution, and strengthens workplace safety.

"This center is new, but our purpose is not. We are, and will always be, a company devoted to homeopathy and natural approaches to health," said Janick Boudazin, CEO of Boiron USA. "More than 300 million people around the world put their trust in homeopathy, and by extension, in us. That trust is something we earn — one customer, one conversation, one order at a time."

Local officials joined the celebration to recognize Boiron's continued investment in the community, reflected in its environmental impact, job creation and long-term commitment to the township. "This is about more than a ribbon cutting. It's about recognizing a company that has invested in our community, believed in our future and chosen to grow right here in Newtown Township. For more than 30 years, Boiron has called Newtown Square home," said Leonard B. Altieri III, Esq., chairman of the Newtown Township Board of Supervisors. "Millions of Americans know the Boiron name because of the company's commitment to quality, wellness and innovation. The new logistics center opening represents a significant investment in both the future of Boiron and the future of Newtown Township."

The event underscored Boiron's deep ties to Newtown Square and its continued commitment to growth, sustainability and operational excellence in the region and across the nation.

For more information about Boiron and its medicines, visit BoironUSA.com.

About Boiron: Since 1932, Boiron has been sharing its passion for homeopathy with a holistic and ecological approach to medicine. Its vision of health care puts people at its center and seeks to improve the quality of their everyday lives. With a long history of unmatched quality and innovation, Boiron remains dedicated to producing the purest of medicines that respect human health and the environment.

SOURCE Boiron USA

Share this article

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

NEW YORK, Sept. 21, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Priority Technology Holdings, Inc. (NASDAQ: PRTH)'s sale to an investor group led by Thomas Priore, the Company's Chairman and Chief Executive Officer, for $8.05 per share in cash. If you are a Priority Technology shareholder, click here to learn more about your rights and options.

MISTRAS Group, Inc. (NYSE: MG)'s sale to affiliates of H.I.G. Capital for $20.35 per share in cash. If you are a MISTRAS shareholder, click here to learn more about your rights and options.

Aethlon Medical, Inc. (NASDAQ: AEMD)'s merger with North Immunology, Inc. Upon closing of the proposed transaction, Aethlon shareholders are expected to own approximately 4.75% of the combined company. If you are an Aethlon shareholder, click here to learn more about your legal rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

One World Trade Center

85th Floor

New York, NY 10007

(212) 763-0060

[email protected]

[email protected]

https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Share this article

Tired of Wearing a Gaming Headset for Hours? COLOLIGHT CHIMERA Offers a Different Way to Hear the Game

Launching September 22 on Kickstarter, CHIMERA reimagines gaming audio without anything worn on your head or over your ears.

NEW YORK and LOS ANGELES, Sept. 21, 2026 /PRNewswire/ -- For many gamers, the longer a gaming session lasts, the more noticeable the headset becomes.

Headband pressure, warm earcups, and the feeling of having something clamped around the head can become distracting after hours of play. COLOLIGHT is taking a different approach with CHIMERA, a chair-mounted open-ear gaming headset launching on Kickstarter on September 22.

Instead of placing speakers directly over the ears, CHIMERA mounts onto the player's gaming chair, positioning its acoustic units around the listener to create a personal open-ear listening zone.

The idea is straightforward: retain the detail and positional information gamers expect from headphones while introducing the more open, spacious character typically associated with speakers — without requiring anything to be worn on the head.

Headset Precision, With a More Open Listening Experience

CHIMERA is built around an open acoustic system featuring a dedicated low-frequency driver and a nine-driver mid/high-frequency array.

The system is designed to deliver impactful bass, detailed mids and highs, and a spacious soundstage across gaming, movies, music, and everyday desktop entertainment.

For competitive gaming, CHIMERA uses a dedicated 2.4 GHz wireless connection with latency as low as 19 ms. Its desktop software also includes game-focused EQ profiles, including FPS presets designed to emphasize important audio cues such as footsteps, reloads, gunfire, and directional movement.

Designed for PC, PS5, Xbox and Different Ways to Play — Plug In and Play with 2.4GHz Wireless

With 2.4GHz wireless connectivity via a plug-and-play USB dongle, CHIMERA is designed for quick and easy use across PC, PlayStation 5, Xbox and other supported gaming devices, making it suitable for players who move between competitive PC gaming, console titles, movies and everyday entertainment.

Its open and spacious presentation is designed to behave differently depending on the type of game being played.

In competitive shooters such as VALORANT, Counter-Strike 2, Call of Duty: Warzone and Apex Legends, positional detail becomes especially important. Footsteps, gunfire and movement cues can help players understand not only what is happening, but where it is happening.

For large-scale games such as Fortnite, the wider presentation can help separate environmental sounds, movement, combat effects and surrounding activity within busy scenes.

In cinematic, story-driven titles such as Cyberpunk 2077, the system is designed to create a more expansive sense of space around dialogue, music, vehicles and environmental effects, bringing the player deeper into the game world.

And in atmospheric action titles such as Elden Ring, CHIMERA's open presentation can help give environmental ambience, orchestral soundtracks and large-scale combat a greater sense of space and scale.

Rather than tuning the experience around a single genre, CHIMERA is designed to move between competitive precision and cinematic immersion depending on what the player is doing.

Built Around the Player — and the Chair

Because CHIMERA mounts directly to the gaming chair, the acoustic units can be adjusted for different chairs, seating positions and body heights.

Players can change the height, distance and angle of the system to position the sound around their preferred listening position.

Once adjusted, there is no headband to reposition and no earcups or earbuds resting directly on the ears, making CHIMERA particularly suited to longer gaming, streaming and desktop sessions.

Communication Without the Traditional Headset

For multiplayer communication, CHIMERA integrates AI-powered ANC and ENC voice-processing algorithms, helping reduce background noise and improve voice clarity during gaming sessions, online calls and team communication.

The goal is to preserve the communication functionality players expect from a gaming headset while changing the physical experience of how gaming audio is delivered.

A Different Kind of Gaming Audio Setup

Traditional headphones, desktop speakers and soundbars each come with their own compromises.

Headphones provide privacy and positional detail but must be worn. Speakers create a more open listening experience, but are affected more heavily by room placement and listening position, while the left and right channels cannot be fully isolated at the listener's ears.

CHIMERA explores a space between the two.

For gamers who enjoy immersive audio but are tired of wearing a headset for hours, CHIMERA is designed to offer another option.

A Launch Offer for Early Backers

COLOLIGHT CHIMERA launches on Kickstarter on September 22, with a $219 Super Early Bird price.

Early supporters will be among the first to experience COLOLIGHT's new approach to chair-mounted open-ear gaming audio.

Those interested in being among the first to experience COLOLIGHT's new approach to chair-mounted open-ear gaming audio can follow the Kickstarter campaign and sign up to receive a launch notification: https://www.kickstarter.com/projects/cololight/cololight-chimera-open-ear-gaming-headset

About COLOLIGHT

COLOLIGHT creates products for gaming rooms and desktop entertainment setups, spanning RGB lighting, gaming audio and desktop accessories designed around immersive gaming environments.

Through products that combine technology, interaction and distinctive industrial design, COLOLIGHT aims to rethink how players experience and personalize the spaces where they game.

SOURCE COLOLIGHT

Share this article

Waymo Co-CEO Tekedra Mawakana to Keynote at CES 2027

Waymo shares future vision for the autonomous ride-hailing service

SAN FRANCISCO, Sept. 21, 2026 /PRNewswire/ -- The Consumer Technology Association (CTA)®, owner and producer of CES®, announces Waymo co-CEO Tekedra Mawakana will deliver a keynote at CES 2027. Waymo is a powerful example of technology moving from novelty to essential daily utility. With its autonomous vehicles serving over half a million trips every week, Waymo is already improving road safety in the communities where it operates, and addressing real-world challenges for seniors and people with limited mobility.

"Whether it's getting to work, catching a flight or heading to a doctor, autonomous vehicles deliver convenience, accessibility and value," said Kinsey Fabrizio, President and CEO, CTA. "Waymo is integrating frontier AI and robotics to create the future of mobility and I look forward to hearing what's next from Tekedra."

Mawakana is one of the leading voices shaping the future of mobility. Mawakana served on the CTA Board of Industry Leaders from 2019 to 2021. Recognized on the TIME 100 AI list and Forbes' 50 Over 50, she regularly speaks on the intersection of technology, leadership and innovation. Her work and impact were featured in The New York Times, Vanity Fair and other leading global publications.

"Waymo is making fully autonomous transportation a seamless part of everyday life," said Mawakana. "We're scaling a service that gives people a safer, more reliable way to get where they need to go. CES is where the world experiences what's next, and with Waymo, you can do more than imagine the future of mobility, you can hail it."

Driven by its mission to be the world's most trusted driver, Waymo is addressing an urgent global crisis: the 1.19 million lives lost annually to traffic crashes. By building a Driver that never gets tired, distracted or impaired and is available 24/7, Waymo sets a higher safety standard. During the CES keynote, Mawakana will detail how the company maintains that safety bar alongside international expansion, fleet evolution, and more.

"Waymo is making transportation safer, more accessible and more efficient," said Gary Shapiro, Executive Chair, CTA. "Tekedra's leadership reflects innovation that improves lives, sparks policy insights and drives the power of technology."

Mawakana speaks at 1:00 p.m. PST on Wednesday, Jan. 6, 2027, in the Palazzo Ballroom at the Venetian. She previously spoke at the CES 2025 Leaders in Technology Dinner.

Visit the Waymo booth 3741 at the Las Vegas Convention Center West Hall from Jan. 6-9. Waymo recently began to welcome its first public riders in Las Vegas – its 15th U.S. market – giving CES attendees an opportunity to experience fully autonomous rides.

Don't miss what's next in autonomous vehicles. The keynote stage will also feature Stellantis. Register for CES 2027 now.

About CES®:

CES is the most powerful tech event in the world – the proving ground for breakthrough technologies and global innovators. This is where the world's biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA)®, CES features every aspect of the tech sector. CES 2027 takes place Jan. 6-9 in Las Vegas. Learn more at CES.tech and follow CES on social.

About Consumer Technology Association (CTA)®:

As North America's largest technology trade association, CTA is the tech sector. Our members are the world's leading innovators – from startups to global brands – helping support more than 17 million American jobs. CTA owns and produces CES® – the most powerful tech event in the world. Find us at CTA.tech. Follow us @CTAtech.

SOURCE Consumer Technology Association

Share this article